Kobayashi Pharmaceutical Co., Ltd. (TYO:4967)
Japan
· Delayed Price · Currency is JPY 5,626.00
-6.00 (-0.11%)
Mar 10, 2026, 10:55 AM JST
Kobayashi Pharmaceutical Cash Flow Statement
Financials in millions JPY. Fiscal year is January - December.
Millions JPY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2017 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2017 |
| Net Income | 3,744 | 13,914 | 27,559 | 27,950 | 27,636 | Upgrade
|
| Depreciation & Amortization | 8,745 | 8,022 | 6,057 | 5,358 | 4,835 | Upgrade
|
| Loss (Gain) From Sale of Assets | 12,656 | 50 | 118 | 121 | 378 | Upgrade
|
| Loss (Gain) From Sale of Investments | -3,041 | -635 | -436 | 89 | -84 | Upgrade
|
| Other Operating Activities | -4,258 | -7,493 | -8,359 | -8,007 | -8,396 | Upgrade
|
| Change in Accounts Receivable | -2,395 | 4,780 | -3,781 | 8,296 | -1,523 | Upgrade
|
| Change in Inventory | 1,392 | -1,144 | -3,175 | -1,977 | -462 | Upgrade
|
| Change in Accounts Payable | 7,748 | -9,447 | 361 | 515 | -158 | Upgrade
|
| Change in Other Net Operating Assets | 999 | 3,199 | 16 | -431 | 193 | Upgrade
|
| Operating Cash Flow | 25,590 | 11,246 | 18,360 | 31,914 | 22,419 | Upgrade
|
| Operating Cash Flow Growth | 127.55% | -38.75% | -42.47% | 42.35% | -6.53% | Upgrade
|
| Capital Expenditures | -13,253 | -26,056 | -12,756 | -14,747 | -3,663 | Upgrade
|
| Sale of Property, Plant & Equipment | 2,624 | 22 | 5 | 3 | 10 | Upgrade
|
| Cash Acquisitions | - | - | -11,176 | - | - | Upgrade
|
| Divestitures | - | - | - | - | 200 | Upgrade
|
| Sale (Purchase) of Intangibles | -758 | -573 | -813 | -1,482 | -522 | Upgrade
|
| Investment in Securities | 10,934 | 8,053 | 5,395 | 2,168 | 12,095 | Upgrade
|
| Other Investing Activities | 299 | 139 | -231 | -254 | -129 | Upgrade
|
| Investing Cash Flow | -154 | -18,415 | -19,576 | -14,312 | 7,991 | Upgrade
|
| Short-Term Debt Repaid | - | - | - | -1 | -12 | Upgrade
|
| Total Debt Repaid | - | - | - | -1 | -12 | Upgrade
|
| Net Debt Issued (Repaid) | - | - | - | -1 | -12 | Upgrade
|
| Repurchase of Common Stock | - | - | -12,000 | -14,056 | -3,943 | Upgrade
|
| Common Dividends Paid | -7,653 | -7,505 | -7,223 | -6,509 | -6,251 | Upgrade
|
| Other Financing Activities | -268 | -263 | -240 | -193 | -171 | Upgrade
|
| Financing Cash Flow | -7,921 | -7,768 | -19,463 | -20,759 | -10,377 | Upgrade
|
| Foreign Exchange Rate Adjustments | 1,204 | 1,220 | 890 | 673 | 797 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | - | - | -22 | - | Upgrade
|
| Net Cash Flow | 18,719 | -13,717 | -19,789 | -2,506 | 20,830 | Upgrade
|
| Free Cash Flow | 12,337 | -14,810 | 5,604 | 17,167 | 18,756 | Upgrade
|
| Free Cash Flow Growth | - | - | -67.36% | -8.47% | -7.11% | Upgrade
|
| Free Cash Flow Margin | 7.44% | -8.94% | 3.23% | 10.33% | 12.08% | Upgrade
|
| Free Cash Flow Per Share | 165.96 | -199.22 | 73.89 | 222.57 | 240.08 | Upgrade
|
| Cash Interest Paid | 28 | 34 | 22 | 18 | 17 | Upgrade
|
| Cash Income Tax Paid | 4,189 | 7,471 | 8,358 | 8,003 | 8,464 | Upgrade
|
| Levered Free Cash Flow | 18,250 | -13,061 | 2,535 | 11,183 | 14,511 | Upgrade
|
| Unlevered Free Cash Flow | 18,267 | -13,043 | 2,553 | 11,194 | 14,522 | Upgrade
|
| Change in Working Capital | 7,744 | -2,612 | -6,579 | 6,403 | -1,950 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.